Drug: bevacizumab Quarter: 2016Q3
Total Records: 786 Number of Pages: 40
| DRUGNAME | PT | EventCount |
|---|---|---|
| BEVACIZUMAB | Injection site pain | 1 |
| BEVACIZUMAB | Injection site pustule | 1 |
| BEVACIZUMAB | Injection site vesicles | 1 |
| BEVACIZUMAB | Instillation site reaction | 1 |
| Bevacizumab | Intentional product misuse | 1 |
| Bevacizumab | Intestinal ischaemia | 1 |
| Bevacizumab | Intraventricular haemorrhage | 1 |
| Bevacizumab | Joint effusion | 1 |
| Bevacizumab | Keratitis | 1 |
| Bevacizumab | Kidney infection | 1 |
| Bevacizumab | Large intestinal haemorrhage | 1 |
| Bevacizumab | Large intestine anastomosis | 1 |
| Bevacizumab | Lenticular opacities | 1 |
| Bevacizumab | Leukaemia | 1 |
| Bevacizumab | Lipase | 1 |
| BEVACIZUMAB | Lung cancer metastatic | 1 |
| Bevacizumab | Lung disorder | 1 |
| Bevacizumab | Lung infiltration | 1 |
| BEVACIZUMAB | Mastication disorder | 1 |
| Bevacizumab | Medication error | 1 |
Total Records: 786 Number of Pages: 40